Health Condition 1: H409- Unspecified glaucoma
Conditions
Interventions
None listed
Sponsors
Elisar Life Sciences pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion into the control group: Normal subjects will be recruited who has: 1. Intraocular pressure (IOP) in AT 2. Optic disc examination graded as normal. 3. No family history of glaucoma. Inclusion into glaucoma group: 1. Glaucoma diagnosis will be based on the presence of typical glaucomatous optic disc damage (i. e. Cup: disc ratio > 0.6, localized rim loss, optic disc hemorrhage, or cup-to-disc asymmetry > 0.2), 2. IOP in AT > 21 mmHg. 3. Glaucoma of any type without any secondary complications. 4. Glaucomatous Optic Neuropathy (GON) detection by glaucoma expert.
Exclusion criteria
Exclusion criteria: 1. Subjects who have undergone ocular surgeries, with ocular disease, amblyopia, neurological disorders will be excluded from the study. 2. Subjects will be excluded with systemic or ocular disease other than glaucoma that might interfere with visual field results. 3. The cataract greater than moderate lens opacification will be excluded from the study as per the LOCS III grading system. 4. Using a miotic drug will be excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic ability of Advanced Vision Analyser (AVA)Timepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The comparison of Elisar Advanced Vision Analyser and clinical diagnosisTimepoint: 3 months | — |
Countries
India
Contacts
Public ContactLavanya
Elisar Life Sciences Pvt, Ltd.
Outcome results
None listed